In silicoevaluation of warfarin-bucolome therapy-Reference-Cited by-同舟云学术

In silicoevaluation of warfarin-bucolome therapy

Published:2016-05 Issue:4 Volume:37 Page:233-242
ISSN:0142-2782
Container-title:Biopharmaceutics & Drug Disposition
language:en
Short-container-title:Biopharm. Drug Dispos.

Author:

Ohtani Hisakazu¹,Hakoda Ryoko¹,Imaoka Ayuko¹,Akiyoshi Takeshi¹

Affiliation:

1. Division of Clinical Pharmacy; Keio University Faculty of Pharmacy, 1-5-30; Shibakoen Minato-ku Tokyo 105-8512 Japan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/bdd.2008/fullpdf

Reference14 articles.

1. Pharmacogenetics of warfarin elimination and its clinical implication;Takahashi;Clin Pharmacokinet,2001

2. Usefulness of coadministration of bucolome in warfarin therapy: pharmacokinetic and pharmacodynamic analysis using outpatient prescriptions;Osawa;Int J Pharm,2005

3. Effects of combination therapy with warfarin and bucolome for anticoagulation in patients with atrial fibrillation;Obata;Circ J,2010

4. Risk and benefits of combined use of bucolome and warfarin in anticoagulation therapy;Hayakawa;Int Heart J,2010

5. Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: application of in vitro approaches to predicting in vivo reduction of (S)-warfarin clearance;Takahashi;Drug Metab Dispos,1999

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Warfarin–A natural anticoagulant: A review of research trends for precision medication;Phytomedicine;2024-06

2. A physiologically based pharmacokinetic/pharmacodynamic modeling approach for drug-drug interaction evaluation of warfarin enantiomers with sorafenib;Drug Metabolism and Pharmacokinetics;2021-08

3. Utilization of Physiologically Based Pharmacokinetic Modeling in Clinical Pharmacology and Therapeutics: an Overview;Current Pharmacology Reports;2020-05-12